Berger Montague PC, national plaintiffs' law firm, announces a class action lawsuit against LifeMD, Inc. (NASDAQ: LFMD) (“LifeMD” or the “Company”) on behalf of investors who purchased or acquired shares during the period fromMay 7, 2025 through August 5, 2025 (the “Class Period”).
https://mma.prnewswire.com/media/232479/berger_montague.jpg
Investor Deadline: Investors who purchased or acquired LifeMD securities during the Class Period may, no later than October 27, 2025, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE.
LifeMD, headquartered in New York, New York, is a telehealth provider offering direct-to-patient virtual care and pharmacy services.
According to the suit, LifeMD issued materially false and/or misleading statements regarding its business and financial outlook. Specifically, the Company is accused of overstating its competitive position and raising its 2025 guidance without adequately accounting for escalating customer acquisition costs-particularly within its RexMD segment and for obesity-related drugs like Wegovy and Zepbound.
When the true facts were revealed, LifeMD shares fell 44%, or $5.31 per share, in a single trading session.
If you are a LifeMD investor and would like to learn more about this action, CLICK HEREor please contact Berger Montague: Andrew Abramowitz at aabramowitz@bergermontague.com or (215) 875-3015, or Caitlin Adorni at cadorni@bergermontague.com or (267)764-4865.
About Berger MontagueBerger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto has been a pioneer in securities class action litigationsince its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
For more information or to discuss your rights, please contact:Andrew AbramowitzSenior CounselBerger Montague(215) 875-3015aabramowitz@bergermontague.com
Caitlin AdorniDirector of Portfolio and Institutional Client Monitoring ServicesBerger Montague(267) 764-4865cadorni@bergermontague.com
https://c212.net/c/img/favicon.png?sn=DC65769&sd=2025-09-04
View original content to download multimedia:https://www.prnewswire.com/news-releases/berger-montague-pc-investigates-securities-claims-against-lifemd-inc-nasdaq-lfmd-302546707.html
SOURCE Berger Montague
https://rt.newswire.ca/rt.gif?NewsItemId=DC65769&Transmission_Id=202509041151PR_NEWS_USPR_____DC65769&DateId=20250904